Jenburkt Pharmaceuticals Ltd share price logo

Jenburkt Pharmaceuticals Ltd

NSE: JENBURPH

BSE: 524731

Small Cap

Pharma Sector

₹1003.90

-22.90

(-2.23%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Jenburkt Pharmaceuticals Stock Performance

as on September 11, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹998.60
    ₹1,034.80
    downward going graph

    0.53%

    Downside

    3.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹998.60
    ₹1,073.90
    downward going graph

    0.53%

    Downside

    6.97%

    Upside

    downward going graph

Jenburkt Pharmaceuticals share price movements today

Previous Close
₹1,026.80
Open
₹1,020.00
Volume
1,783.00
Upper Circuit
₹1,232.10
Lower Circuit
₹821.50
Day's Low - High
₹998.60 - ₹1,034.80
52 Week Low - High
₹998.60 - ₹1,073.90

Jenburkt Pharmaceuticals Historical Returns

1 Month Return
-4.61 %
3 Month Return
-14.53 %
1 Year Return
-8.23 %
3 Year Return
+ 42.8 %
5 Year Return
+ 103.94 %

Jenburkt Pharmaceuticals Fundamentals

as on September 11, 2026 at 4:01 pm IST

Market Cap

₹443.05 Cr

Return on Equity (ROE)

18.84

PE Ratio (TTM)

13.5

Return on capital employed (ROCE)

24.65

Industry PE ratio

51.81

Beta (LTM)

0.78

P/B Ratio

2.14

Dividend Yield

0

PEG Ratio

15.16

Quarterly Earnings Growth YOY

-24.39

EPS (TTM)

0

Book Value

0

Jenburkt Pharmaceuticals Stock Valuation

as on September 11, 2026 at 4:01 pm IST

Jenburkt Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (9.47x)

July 1, 2022

Today (13.50x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (19.32x)

December 17, 2024

LowHigh

Today’s Price to Earnings Ratio: 13.50x

Jenburkt Pharmaceuticals Technical Analysis

Track how Jenburkt Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish8
Bullish4
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.88
Bullish
CCI (20)
15.61
Neutral
RSI (14)
47.91
Neutral
Momentum (10)
3.8
Bullish
ADI (14)
38.37
Bullish
Ultimate Oscillator (7,14,28)
46.1
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1014.44
Bearish
EMA (20)
1015.35
Bearish
VWMA (20)
1015.85
Bearish
SMA (50)
1017.94
Bearish
EMA (50)
1017.42
Bearish
SMA (200)
1024.37
Bearish
EMA (200)
1022.73
Bearish
KAMA (200)
1007.39
Bullish
DEMA (200)
1020.12
Bearish

Jenburkt Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jenburkt Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Jenburkt Pharmaceuticals Ltd image
Jenburkt Pharmaceuticals Ltd
BUY443.0520.79%0.0034168
Aptus Pharma Ltd image
Aptus Pharma Ltd
NA582.93180.29%0.00446
Vaishali Pharma Ltd image
Vaishali Pharma Ltd
NA114.4226.53%0.00699
FDC Ltd image
FDC Ltd
NA5,559.15-1.5%0.512812,170
Gufic BioSciences Ltd image
Gufic BioSciences Ltd
NA4,263.0122.92%0.7064944
See all

Market expectation of Jenburkt Pharmaceuticals Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Jenburkt Pharmaceuticals Stock’s Investor Sentiment and Interest

Search interest for Jenburkt Pharmaceuticals Ltd Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:20% versus previous 30 day period

Jenburkt Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
38.29
35.66
38.84
32.54
41.22
36.89
41.05
35.53
45.56
43.02
44.63
35.51
Other Income
1.1
1.35
1.19
1.41
1.85
1.58
1.88
2.06
2.08
1.82
4.35
1.51
Total Income
39.38
37.01
40.03
33.94
43.07
38.47
42.93
37.58
47.64
44.84
48.98
37.03
Expenses
29.18
28.47
28.99
23.25
29.79
28.07
30.19
26.57
32.45
35.59
34.33
29.49
Operating Profit
9.11
7.19
9.85
9.29
11.43
8.82
10.86
8.96
13.11
7.43
10.3
6.02
Operating Profit Margin %
23.79%
20.16%
25.36%
28.55%
27.73%
23.91%
26.46%
25.22%
28.78%
17.27%
23.08%
16.95%
Profit Before Interest, Tax and Depreciation
10.2
8.54
11.04
10.7
13.28
10.4
12.74
11.01
15.18
9.24
14.65
7.54
Interest
0.07
0.07
0.06
0.11
0.12
0.11
0.11
0.11
0.11
0.12
0.13
0.13
Depreciation
0.59
0.63
0.62
0.52
0.64
0.78
0.79
0.72
0.74
0.83
0.81
0.64
Profit Before Tax
9.54
7.84
10.36
10.07
12.52
9.51
11.84
10.18
14.33
8.29
13.71
6.77
Tax Paid
2.22
2.44
2.48
2.65
2.92
3.01
3.3
2.39
4.17
2.37
2.86
0.88
Profit After Tax
7.32
5.4
7.88
7.42
9.6
6.51
8.54
7.79
10.16
5.93
10.85
5.89
Total Net profit including share of profit / Loss from associate company
7.32
5.4
7.88
7.42
9.6
6.51
8.54
7.79
10.16
5.93
10.85
5.89
EPS
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44
24.58
13.34
Actual EPS
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44
24.58
13.34
Adjusted EPS
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44
24.58
13.34
Diluted EPS
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44
24.58
13.34

Jenburkt Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
114.67
122.64
118.89
109.29
123.98
136.75
141.97
151.69
168.74
Other Income
3.39
3.41
4.22
4.31
4.95
5.12
4.67
6.72
10.3
Total Income
118.07
126.05
123.11
113.6
128.93
141.87
146.63
158.41
179.04
Expenses
90.89
97.68
99.15
89.45
96.73
106.38
108.85
111.3
128.95
Operating Profit
23.78
24.96
19.74
19.84
27.25
30.37
33.12
40.39
39.79
Operating Profit Margin %
20.74%
20.35%
16.6%
18.15%
21.98%
22.21%
23.33%
26.63%
23.58%
Profit Before Interest, Tax and Depreciation
27.18
28.37
23.96
24.15
32.2
35.49
37.79
47.11
50.09
Interest
0.41
0.39
0.53
0.47
0.43
0.37
0.27
0.45
0.46
Depreciation
1.5
1.35
2.3
2.04
1.9
2.26
2.34
2.73
3.11
Profit Before Tax
25.27
26.63
21.13
21.64
29.87
32.86
35.18
43.93
46.52
Tax Paid
8.05
6.83
6.27
5.14
7.58
8.25
9.2
11.87
11.78
Profit After Tax
17.21
19.8
14.87
16.5
22.3
24.61
25.98
32.06
34.74
Total Net profit including share of profit / Loss from associate company
17.21
19.8
14.87
16.5
22.3
24.61
25.98
32.06
34.74
EPS
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
78.71
Actual EPS
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
78.71
Adjusted EPS
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
78.71
Diluted EPS
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
78.71

Jenburkt Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
7.82
9.95
16.18
12.99
15.02
19.45
9.27
17.05
8.12
27.91
26.52
Cash Flow from Investing Activities
-0.27
-9.77
1.01
-10.53
-2.87
-18.78
-1.19
2.62
-0.59
-17.05
-19.45
Cash Flow from Financing Activities
-5.42
0.68
-17.98
-2.43
-10.84
-0.72
-5.53
-21.05
-7.08
-7.62
-8.86
Net Cash Flow
2.13
0.86
-0.8
0.04
1.31
-0.04
2.54
-1.37
0.47
3.24
-1.79

Jenburkt Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
47.39%
47.23%
46.71%
46.71%
46.69%
46.68%
46.67%
46.66%
46.65%
46.64%
46.62%
DII
0%
0%
0%
0%
0.12%
0.12%
0.12%
0.12%
0.12%
0.12%
0.12%
Public
52.61%
52.77%
53.29%
53.29%
53.2%
53.2%
53.22%
53.22%
53.24%
53.25%
53.26%
Total Outstanding Shares
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
Total Shareholders
6,021
6,316
6,419
6,628
6,901
6,987
6,712
6,855
7,163
6,999
7,103

Jenburkt Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Jenburkt Pharmaceuticals.

  • Jenburkt Pharmaceuticals Ltd Earnings Results

    Jenburkt Pharmaceuticals Ltd’s net profit fell -24.39% since last year same period to ₹5.89Cr in the Q1 2026-2027. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -45.71% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Jenburkt Pharmaceuticals Ltd Dividends May,2026

    In the quarter ending March 2026, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹20.70 per share on 05 May 2026 - translating a dividend yield of 2.06%.

    Read More about Dividends

Insights on Jenburkt Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 53.25% to 53.26% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 53.9% return, outperforming this stock by 62.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 165.7% return, outperforming this stock by 122.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, JENBURPH stock has moved down by -14.5%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.64% to 46.62% in Jun 2026 quarter

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd. is a well-established healthcare and pharmaceutical venture, formed by the Bhuta family in 1985. By being listed on the Bombay Stock Exchange, Jenburkt is a public limited company that specializes in manufacturing and marketing high quality pharmaceutical formulations and healthcare products. Headquartered in Mumbai, Jenburkt runs all its operations from the same location.

Founders of the company, the Bhuta family, help maintain the core values of Jenburkt, as over 35 years of experience in the pharmaceutical industry ensures that its products meet the highest standards of quality and efficiency. With a stellar history and experience in the field, Jenburkt continues to serve the healthcare industry with its unique solutions and services.

Revenue: ₹35.51Cr as on June 2026 (Q1 FY27)
Net Profit: ₹5.89Cr as on June 2026 (Q1 FY27)
Listing date: 17 Aug, 2026
Chairperson Name: Ashish U Bhuta
OrganisationJenburkt Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOAshish U Bhuta
E-voting on sharesClick here to vote

FAQs

What is Jenburkt Pharmaceuticals share price today?

Jenburkt Pharmaceuticals share price today stands at ₹1003.9 as on at the close of the market. Jenburkt Pharmaceuticals share today touched a day high of ₹1034.8 and a low of ₹998.6.

What is the 52 week high and 52 week low range for Jenburkt Pharmaceuticals share?

Jenburkt Pharmaceuticals touched a 52 week high of ₹1073.9 and a 52 week low of ₹998.6. Jenburkt Pharmaceuticals share price today i.e. is closed at ₹1003.9, which is -6.52% down from its 52 week high and 0.53% up from its 52 week low.

What is Jenburkt Pharmaceuticals's market capitalisation today?

Jenburkt Pharmaceuticals market capitalisation is ₹443.05 Cr as on .

How to buy Jenburkt Pharmaceuticals shares?

To buy Jenburkt Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for JENBURPH or Jenburkt Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Jenburkt Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Jenburkt Pharmaceuticals trading volume today?

Jenburkt Pharmaceuticals trading volume is 1,783.00 as on . This means that 1,783.00 shares of Jenburkt Pharmaceuticals were bought and sold on the stock market during today's trading session.